Drug: omalizumab Quarter: 2016Q3
Total Records: 175 Number of Pages: 9
| DRUGNAME | PT | EventCount |
|---|---|---|
| Omalizumab | Dysphonia | 4 |
| Omalizumab | Fibromyalgia | 4 |
| Omalizumab | Heart rate increased | 4 |
| Omalizumab | Hypersensitivity | 4 |
| Omalizumab | Hypotension | 4 |
| Omalizumab | Lower respiratory tract infection | 4 |
| Omalizumab | Myalgia | 4 |
| Omalizumab | Peripheral swelling | 4 |
| Omalizumab | Pulse volume decreased | 4 |
| Omalizumab | Sinus congestion | 4 |
| Omalizumab | Sleep apnoea syndrome | 4 |
| Omalizumab | Suffocation feeling | 4 |
| Omalizumab | Throat irritation | 4 |
| Omalizumab | Tooth abscess | 4 |
| Omalizumab | Wheezing | 4 |
| Omalizumab | Wound | 4 |
| Omalizumab | Bronchiolitis | 3 |
| Omalizumab | Ear infection | 3 |
| Omalizumab | Foetal exposure during pregnancy | 3 |
| Omalizumab | Lip swelling | 3 |
Total Records: 175 Number of Pages: 9